AstraZeneca (AZ) has a bold aspiration to improve the lives of 200 million patients delivering 20 new medicines to patients by 2030. This role is critical in contributing to AZ’s long-term ambition. Global Business Services (GBS) is growing to support critical functions across the whole Enterprise. This role will be specifically focused on defining and delivering GBS opportunities within the R&D areas of the business. 

Post : Clinical Data Scientist

ECHS Unites application to engage the following vacancies Medical. Para Medical & Non Medical Staff on contractual basis in 02 x Polyclinic. Devlali and Dhule for a period of one year renewable for additional period of one year/ till attaining the maximum age subject to performance of candidates/ other conditions according to the criteria as mentioned against each post :

Post : Pharmacist

The BREATH programme, co-financed with European funds, opens the second call to attract international talent

Novo Nordisk has announced that it has filed a lawsuit against Eli Lilly and Company in the United States, alleging that Lilly's advertising campaigns for its GLP-1 medicines are misleading and do not present complete scientific information.

Global pharmaceutical company Sanofi has received a Public Reprimand from the Prescription Medicines Code of Practice Authority (PMCPA) after a complaint was filed by Pfizer.

The PMCPA investigated the case (CASE/0689/08/25) and found that Sanofi had breached several rules of the 2024 ABPI Code of Practice, which sets standards for how pharmaceutical companies should promote their medicines in the UK.